medigraphic.com
ISSN 1665-2576 (Print)

2012, Number 2

<< Back Next >>

Rev Mex Cir Endoscop 2012; 13 (2)

Cardiovascular risk analysis in gastric bypass patients

Torres RMF, Romero LLS, Bravo TCC, Aguirre OI, Morales VJM, Rojano M

Language: Spanish
References: 22
Page: 66-70
PDF size: 50.58 Kb.


ABSTRACT

Introduction: Obesity is considered a predisposing risk factor for developing acute coronary events; however, the major factors in developing these types of events are those that involve the metabolic syndrome, present in most patients undergoing some type of bariatric surgery. Objective: To compare the cardiovascular risk in the bariatric surgery patients at the Hospital General «Dr. Manuel Gea González» performed prior to surgery and then two years after the procedure. Material and methods: Retrospective analysis of patients of the bariatric surgery clinic. We analyzed all the variants of the Framingham method preoperatively and two years after surgery, and compared the cardiovascular risk according to this method. Results: 64 patients were included. The average age of the group of men was 42 years, preoperatively, the mean BMI was 49.44, the cardiovascular risk score was: 5.15 (2-9), to a two years follow up average BMI was 36.23 (27.68-44.34), the cardiovascular risk score was 2.38 (0-5). In the group of women the average age was 38 years (18 to 56) preoperatively, the mean BMI was 45.32 (34.4-53.3) the cardiovascular risk score was 4.3 (-10 to 13) to a two years follow up the mean BMI was 28.64 (20.1 -42.1), the cardiovascular risk score was -4.1 (-11 to 8). Conclusions: Bypass gastric surgery in obese patients has not only proven to be effective and safe in patients with metabolic syndrome but also reduce the high cardiovascular risk that some patients have.


REFERENCES

  1. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.

  2. Dawber TR. The Framingham study. The epidemiology of atherosclerosis disease. Cambridge, MA: Harvard University Press 1980: 1-68.

  3. Alcocer LA, Lozada O, Fanghänel G, Sánchez-Reyes L, Campos-Franco E. Estratificación del riesgo cardiovascular global. Comparación de los métodos Framingham y SCORE en población mexicana del estudio PRIT. Cir Cir 2011; 79: 168-174.

  4. Li TY, Rana JS, Manson JE. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation 2006; 113: 499-506.

  5. Leslie D, Kellogg TA, Ikramuddin S. Bariatric surgery primer for the internist: keys to the surgical consultation. Med Clin N Am 2007; 91: 353-381.

  6. Folli F, Pontiroli AE, Schwesinger WH. Metabolic aspects of bariatric surgery. Med Clin N Am 2007; 91: 393-414.

  7. Frangou C. Family physicians still wary of bariatric surgery. General Surgery News 2006: 1-20.

  8. Torquati A, Kelly W, Melvin W, Richards W. Effect of gastric bypass operation on Framingham and actual risk of cardiovascular events in class II to III obesity. J Am Coll Surg 2007; 204: 776-783.

  9. Kligman MD. Shrinking cardiovascular risk through bariatric surgery: application of Framingham risk score in gastric bypass. Surgery 2008; 143: 533-538.

  10. Ocón J, García B, Benito P, Gimeno S, García R, López P. Efecto del bypass gástrico en el síndrome metabólico y en el riesgo cardiovascular. Nutr Hosp 2010; 25: 67-71.

  11. Sjostrom L, Lindroos AK, Peltonen M. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-2693.

  12. DeMaria EJ, Sugerman HJ, Kellum JM. Results of 281 consecutive total laparoscopic Roux-in-Y gastric bypasses to treat morbid obesity. Ann Surg 2002; 235: 640-645.

  13. Schauer PR, Burguera B, Ikramuddin S. Effect of laparoscopic Roux-in-Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467-484.

  14. Torquati A, Lutfi R, Abumrad N. Is Roux-in-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? J Gastrointest Surg 2005; 9: 1112-1116.

  15. Brown CD, Higgins M, Donato KA. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000; 8: 605-619.

  16. Buchwald H, Avidor Y, Braunwald E. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.

  17. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. NIH Publication No. 03-5233 December 2003.

  18. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. NIH Publication No. 02-5215 September 2002.

  19. Nguyen NT, Varela E, Sabio A. Resolution of hyperlipidemia after laparoscopic Roux-in-Y gastric bypass. J Am Coll Surg 2006; 203: 24-29.

  20. Zlabek JA, Grimm MS, Larson CJ. The effect of laparoscopic gastric bypass surgery on dyslipidemia in severely obese patients. Surg Obes Relat Dis 2005; 1: 537-542.

  21. Buchwald H, Williams SE, Matts JP. Overall mortality in the program on the surgical control of the hyperlipidemias. J Am Coll Surg 2002; 195: 327-331.

  22. Gordon T, Kannel WB. Obesity and cardiovascular diseases: the Framingham study. Clin Endocrinol Metab 1976; 5: 367-75.




2020     |     www.medigraphic.com